Companies: 10,795·Total market cap: $144.5T
Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

BMYNYSEHealthcare● Active
$56.92
$-0.36(-0.62%)
Market Cap$116.2B
P/E Ratio
52W High$62.89
52W Low$42.52
Overview

Bristol-Myers Squibb Company (BMY) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

bmy · stock forecast · 41 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 41 Wall Street analysts in the past 3 months

SellBuy

Hold

41 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
19
Hold
20
Sell
2
Strong Sell
0
Total: 41 · Buy rate: 46.3%

12-Month Price Target

High

$75.00

Consensus

$61.73

+7.8% upside

Low

$40.00

Median: $60 · Last Close: $57.27

The Bristol-Myers Squibb Company (BMY) analyst consensus is Hold, based on ratings from 41 Wall Street analysts over the past 3 months. The average 12-month BMY price target is $61.73, representing +7.8% upside from the current price of $57.27.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $62 (7.8%)

Consensus Target

$61.73

7.8% upside

High Target

$75

31.0%

Low Target

$40

-30.2%

Current Price

$57.27

as of today

Based on analyst price targets, the BMY stock price prediction for the next 12 months ranges from $40 to $75. The consensus BMY price forecast of $61.73 implies 7.8% upside from the current price of $57.27.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$56.301.69%

1-day model range: $56.11–$56.49. Peak: $56.49 (-1.69%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$54-5.7%
2028$52-9.2%
2029$51-11.3%
2030$50-12.7%
2031-13.6%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

64%7%29%
9Buy
1Neutral
4Sell
RSI (14)51.2Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · BMY · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$55.60BUY
MA 10$56.71BUY
MA 20$56.96BUY
MA 50$58.02SELL
MA 100$58.33SELL
MA 200$53.21BUY
Current $BMY · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$56.35BUY
EMA 10$56.54BUY
EMA 20$56.95BUY
EMA 50$57.56SELL
EMA 100$56.95BUY
EMA 200$55.05BUY
Current $BMY · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
B of A Securities2026-04-09
Maintains
BuyBuy
Guggenheim2026-04-08
Maintains
BuyBuy
Cantor Fitzgerald2026-04-08
Maintains
NeutralNeutral
HSBC2026-03-17
Maintains
HoldHold
Piper Sandler2026-02-23
Maintains
OverweightOverweight
Guggenheim2026-02-06
Maintains
BuyBuy
Citigroup2026-02-06
Maintains
NeutralNeutral
Wells Fargo2026-02-06
Maintains
Equal WeightEqual Weight
Piper Sandler2026-01-28
Maintains
OverweightOverweight
Citigroup2026-01-27
Maintains
NeutralNeutral

Wall Street analysts have recently issued updated ratings on Bristol-Myers Squibb Company (BMY) stock. Of the recent 293 rating actions, 33 were upgrades and 37 were downgrades. 41 analysts currently cover BMY.

Analyst Recommendation Trends

Buy ratings02↑ +2
Hold ratings11
Sell ratings00

BMY analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 2 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$47.3B

↑ 15.5% YoY

Revenue Next Year

$46.3B

↓ 2.1% YoY

EPS This Year

$6.32

EPS Next Year

$6.14

↓ 2.9% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast BMY EPS of $6.32 for the current fiscal year, based on estimates from 17 analysts. The BMY revenue forecast is $47.3B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The BMY stock forecast is supported by two independent data sources: analyst consensus ratings from 41 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus BMY price target is $61.73 (+7.8% upside), with an analyst consensus of Hold.

The BMY short-term stock prediction for tomorrow is $56.30 (-1.69%). The BMY stock price prediction for 2027 estimates an average of $54. The BMY stock prediction for 2030 projects a range of $48–$52.

Bristol-Myers Squibb Company trades on NYSE under the ticker BMY. The BMY stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 46% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

BMY forecast · 8 questions

According to 41 Wall Street analysts, the average 12-month BMY price target is $61.73, with a high forecast of $75.00 and a low of $40.00. The median price target is shown in the chart above when available. This implies +7.8% potential upside from the current price of $57.27.

BMY price targetWhat is BMY price targetBMY analyst price targetBMY 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.